You are now leaving Abacavir HSR Support. ViiV Healthcare does not recommend, endorse or accept liability for sites controlled by third parties.
The Abacavir Hypersensitivity Reaction (ABC HSR) educational programme has the following aims:
- Maintaining low morbidity and mortality from ABC HSR in general, and to minimise the risk of ABC rechallenge in patients with clinically suspected HSR, regardless of HLA-B*5701 status.
- Increase understanding and awareness of ABC HSR by Healthcare professionals (HCPs) and expand on the information already included in the product labels.
- Increase awareness of ABC HSR by patients via the ABC HSR Alert/Warning card and product labelling.